ASX ANNOUNCEMENT
ADMEDUS TO SHOWCASE CARDIOCEL® AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) ANNUAL MEETING
Key Sponsor of Techno-College, 11th October, 2014
Exhibiting at booth #123, 12th - 14th October, 2014
Admedus hosting CardioCel® Satellite Symposium, 13th October, 2014
Brisbane, Australia, 10th October, 2014
Admedus Limited (ASX:AHZ) announced today its attendance at the European
Association for Cardio-Thoracic Surgery (EACTS) 28th Annual Meeting to be held in
Milan from the 11th -15th October, 2014.
Admedus will be showcasing CardioCel®, its advanced cardiovascular scaffold currently
marketed in Europe and the US, at its booth and at a number of presentations and
symposia. Following CE marking and FDA 510k clearance, CardioCel® is seeing
increasing adoption as the tissue of choice for the repair of congenital heart
deformities, more complex heart defects and heart valve repair procedures.
CardioCel® clinical data will feature on Saturday, 11th October at the Admedus
sponsored Techno-College, where Admedus will also have an exhibition booth. The
Annual Techno-College is an integral part of EACTS and provides an update on the
latest developments in the field of cardiovascular, thoracic and congenital surgery.
Admedus will be exhibiting at booth #123 in the main hall from Sunday evening until
Tuesday evening. A wet lab will be set up in the booth for hands-on CardioCel®
product demonstrations.
The CardioCel® Satellite Symposium will take place from 12:45 – 14:00 on Monday,
13th October at the Milano Congressi in room Amber 6. Chaired by Prof. Mark
Hazekamp, LUMC, The Netherlands, the symposium will comprise surgeon
presentations and an open forum on the CardioCel® scaffold tissue engineering
process and clinical usage to date. Panellists include:
Prof. William Neethling, University of Western Australia;
Prof. Tom Karl, Mater Children’s Hospital, Brisbane;
Mr Olivier Ghez, Royal Brompton Hospital,
real good imo
Expand
(20min delay)